180 related articles for article (PubMed ID: 32486837)
1. Feasibility of Thorium-227/Radium-223 Gamma-Camera Imaging During Radionuclide Therapy.
Larsson E; Brolin G; Cleton A; Ohlsson T; Lindén O; Hindorf C
Cancer Biother Radiopharm; 2020 Sep; 35(7):540-548. PubMed ID: 32486837
[TBL] [Abstract][Full Text] [Related]
2. Quantitative Dual-Isotope Planar Imaging of Thorium-227 and Radium-223 Using Defined Energy Windows.
Murray I; Rojas B; Gear J; Callister R; Cleton A; Flux GD
Cancer Biother Radiopharm; 2020 Sep; 35(7):530-539. PubMed ID: 32429699
[No Abstract] [Full Text] [Related]
3. Development of separation technology for the removal of radium-223 from targeted thorium conjugate formulations. Part I: purification of decayed thorium-227 on cation exchange columns.
Frenvik JO; Dyrstad K; Kristensen S; Ryan OB
Drug Dev Ind Pharm; 2017 Feb; 43(2):225-233. PubMed ID: 27628177
[TBL] [Abstract][Full Text] [Related]
4. Assessment of collimators in radium-223 imaging with channelized Hotelling observer: a simulation study.
Takahashi A; Baba S; Sasaki M
Ann Nucl Med; 2018 Dec; 32(10):649-657. PubMed ID: 30073570
[TBL] [Abstract][Full Text] [Related]
5. Practical considerations for quantitative clinical SPECT/CT imaging of alpha particle emitting radioisotopes.
Benabdallah N; Scheve W; Dunn N; Silvestros D; Schelker P; Abou D; Jammalamadaka U; Laforest R; Li Z; Liu J; Ballard DH; Maughan NM; Gay H; Baumann BC; Hobbs RF; Rogers B; Iravani A; Jha AK; Dehdashti F; Thorek DLJ
Theranostics; 2021; 11(20):9721-9737. PubMed ID: 34815780
[No Abstract] [Full Text] [Related]
6. Quantitative imaging of 223Ra-chloride (Alpharadin) for targeted alpha-emitting radionuclide therapy of bone metastases.
Hindorf C; Chittenden S; Aksnes AK; Parker C; Flux GD
Nucl Med Commun; 2012 Jul; 33(7):726-32. PubMed ID: 22513884
[TBL] [Abstract][Full Text] [Related]
7. Development of separation technology for the removal of radium-223 from targeted thorium conjugate formulations. Part II: purification of targeted thorium conjugates on cation exchange columns.
Frenvik JO; Dyrstad K; Kristensen S; Ryan OB
Drug Dev Ind Pharm; 2017 Sep; 43(9):1440-1449. PubMed ID: 28402142
[TBL] [Abstract][Full Text] [Related]
8. Preclinical Single Photon Emission Computed Tomography of Alpha Particle-Emitting Radium-223.
Abou DS; Rittenbach A; Tomlinson RE; Finley PA; Tsui B; Simons BW; Jha AK; Ulmert D; Riddle RC; Thorek DLJ
Cancer Biother Radiopharm; 2020 Sep; 35(7):520-529. PubMed ID: 32182119
[No Abstract] [Full Text] [Related]
9. [A Comparison of Planar Sensitivity and Spatial Resolution among Different Collimators and Energy Windows on
Umeda T; Miyaji N; Nakazawa S; Miwa K; Wagatsuma K; Motegi K; Takiguchi T; Koizumi M
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2017; 73(11):1132-1139. PubMed ID: 29151546
[TBL] [Abstract][Full Text] [Related]
10. Development of separation technology for the removal of radium-223 from decayed thorium-227 in drug formulations. Material screening and method development.
Frenvik JO; Kristensen S; Ryan OB
Drug Dev Ind Pharm; 2016 Aug; 42(8):1215-24. PubMed ID: 26569601
[TBL] [Abstract][Full Text] [Related]
11. Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting (223)Ra-dichloride.
Pacilio M; Ventroni G; De Vincentis G; Cassano B; Pellegrini R; Di Castro E; Frantellizzi V; Follacchio GA; Garkavaya T; Lorenzon L; Ialongo P; Pani R; Mango L
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):21-33. PubMed ID: 26266887
[TBL] [Abstract][Full Text] [Related]
12. Planar gamma camera imaging and quantitation of yttrium-90 bremsstrahlung.
Shen S; DeNardo GL; Yuan A; DeNardo DA; DeNardo SJ
J Nucl Med; 1994 Aug; 35(8):1381-9. PubMed ID: 8046498
[TBL] [Abstract][Full Text] [Related]
13. The potential radio-immunotherapeutic α-emitter
Collins SM; Keightley JD; Ivanov P; Arinc A; Fenwick AJ; Pearce AK
Appl Radiat Isot; 2019 Mar; 145():251-257. PubMed ID: 30686576
[TBL] [Abstract][Full Text] [Related]
14. Revisiting gallium-67 imaging: investigation of the energy photopeaks.
Ali L; Khalil M; Hadi N
Nucl Med Commun; 2010 Dec; 31(12):1068-74. PubMed ID: 20881893
[TBL] [Abstract][Full Text] [Related]
15. Optimized SPECT Imaging of
Mikalsen LTG; Kvassheim M; Stokke C
J Nucl Med; 2023 Jul; 64(7):1131-1137. PubMed ID: 37268424
[TBL] [Abstract][Full Text] [Related]
16. Multi-isotope SPECT imaging of the
Robertson AKH; Ramogida CF; Rodríguez-Rodríguez C; Blinder S; Kunz P; Sossi V; Schaffer P
Phys Med Biol; 2017 Jun; 62(11):4406-4420. PubMed ID: 28362640
[TBL] [Abstract][Full Text] [Related]
17. Radiochemical Quality Control Methods for Radium-223 and Thorium-227 Radiotherapies.
Hasson A; Jiang W; Benabdallah N; Lu P; Longtine MS; Beattie BJ; Summer L; Zhang H; Wahl RL; Abou DS; Thorek DLJ
Cancer Biother Radiopharm; 2023 Feb; 38(1):15-25. PubMed ID: 36149725
[No Abstract] [Full Text] [Related]
18. The potential radio-immunotherapeutic α-emitter
Collins SM; Keightley JD; Ivanov P; Arinc A; Jerome SM; Fenwick AJ; Pearce AK
Appl Radiat Isot; 2019 Mar; 145():240-250. PubMed ID: 30583971
[TBL] [Abstract][Full Text] [Related]
19. A Monte Carlo study on (223)Ra imaging for unsealed radionuclide therapy.
Takahashi A; Miwa K; Sasaki M; Baba S
Med Phys; 2016 Jun; 43(6):2965-2974. PubMed ID: 27277045
[TBL] [Abstract][Full Text] [Related]
20. Influence of high-energy photons on the spectrum of iodine-123 with low- and medium-energy collimators: consequences for imaging with 123I-labelled compounds in clinical practice.
Dobbeleir AA; Hambÿe AS; Franken PR
Eur J Nucl Med; 1999 Jun; 26(6):655-8. PubMed ID: 10369952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
